GlassScriptPhysician profile
Natasha Roberts
NPI 1053796474
$1,820.12
in general payments reported to CMS, 2019-2025
14 companies · $63.64 in 2025
The $63.64 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $839 · 2022: $323 · 2023: $189 · 2024: $405 · 2025: $63.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $500.00 | 2021 | |
| Abbott Laboratories | $351.85 | 2021-2023 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Merz North America, INC. | $348.98 | 2023-2024 | Xeomin |
| Solta Medical, A Division of Bausch Health US, LLC | $164.96 | 2024 | |
| Abbvie INC. | $131.39 | 2021-2024 | |
| Zoll Circulation INC | $129.16 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $46.98 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.25 | 2022 | |
| Cvrx, INC. | $24.58 | 2025 | Barostim Neo System |
| Pfizer INC. | $22.84 | 2021 | |
| Bioventus LLC | $21.50 | 2025 | Durolane |
| Amgen INC. | $19.30 | 2021 | |
| Currax Pharmaceuticals LLC | $17.56 | 2025 | Contrave |
| Advanced Respiratory, INC | $15.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.